|
Volumn 75, Issue 6, 2006, Pages 1108-1112
|
Oral rehydration solution to prevent nephrotoxicity of amphotericin B
g
NONE
(Peru)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B DEOXYCHOLATE;
AMPHOTERICIN B LIPID COMPLEX;
CREATININE;
POTASSIUM;
SODIUM;
SODIUM CHLORIDE;
UREA;
AMPHOTERICIN B;
ANTIPROTOZOAL AGENT;
ABDOMINAL PAIN;
ADULT;
ANOREXIA;
ARTHRALGIA;
ARTICLE;
CHILL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CREATININE CLEARANCE;
DRUG WITHDRAWAL;
FEMALE;
FEVER;
GLOMERULONEPHRITIS;
HEADACHE;
HUMAN;
HUMAN TISSUE;
HYPOKALEMIA;
HYPONATREMIA;
KIDNEY FUNCTION TEST;
LEISHMANIASIS;
MALAISE;
MALE;
MYALGIA;
NEPHROTOXICITY;
OPEN STUDY;
ORAL REHYDRATION THERAPY;
POTASSIUM BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL;
SODIUM BLOOD LEVEL;
TREATMENT OUTCOME;
UREA BLOOD LEVEL;
DRUG EFFECT;
FLUID THERAPY;
KIDNEY;
MIDDLE AGED;
PATHOLOGY;
ADULT;
AMPHOTERICIN B;
ANTIPROTOZOAL AGENTS;
FLUID THERAPY;
HUMANS;
KIDNEY;
KIDNEY FUNCTION TESTS;
LEISHMANIASIS;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 39049180662
PISSN: 00029637
EISSN: None
Source Type: Journal
DOI: 10.4269/ajtmh.2006.75.1108 Document Type: Article |
Times cited : (18)
|
References (30)
|